The development of effective vaccines is one the greatest public health successes in history, but new insights and discoveries are needed for pathogens without vaccines. Moreover, many of the biggest killers and greatest needs for new advances in human health are now recognized as involving the immune system:
|
|
|
|
|
The Program in Immunology was created to address the growing need for cross-disciplinary discussions and collaborations to advance the drive toward new therapies. The Program brings together a community of investigators interested in discovery and therapeutic development. By combining Vanderbilt’s strengths in basic and clinical science, we are poised to make numerous exciting discoveries. For instance:
The Mass Spectrometry Research Center provide a platform for using both proteomics and genomics to gain insights into the subcellular machinery responsible for causing disease.
The Vanderbilt Institute for Imaging Sciences permits the study of the host-pathogen interaction with unprecedented resolution.
An integrated program of genomic sciences, http://vantage.vanderbilt.edu
The Vanderbilt Institute of Chemical Biology facilitates the discovery of novel chemical probes and provides a pathway for Vanderbilt investigators to bring candidate therapeutics to the clinic.
Vanderbilt’s Center for Human Genetics Research provides investigators the opportunity to study the impact of human genotype on susceptibility to infection, and the trend-setting BioVU system allows novel explorations of the connection between individual genetics and clinical histories.
Vanderbilt’s Institute for Integrative Biomedical Research, VIIBRE, offers one among the many mechanisms for development and application of novel engineering tools to biological problems: http://www.vanderbilt.edu/viibre/
Finally, numerous state-of-the-art Core Facilities dramatically expand our technical capabilities.
These are just some of the Vanderbilt resources that are being employed by Program investigators to make important discoveries in the area of immunology. Exciting times exciting people!
This page was last updated February 26, 2013 and is maintained by Andries Zijlstra